$190.84
1.710.90%
At close: May 7, 5:00 PM EST
$190.84
N/A
After Hours: 4:00 PM EST
Quest Diagnostics Inc Stock Guidance
DGXNYSE
Quest Diagnostics (DGX) last issued guidance on April 21, 2026 for fiscal year 2026. The company guided earnings per share in the range of $10.63 - $10.83, compared to a consensus EPS estimate of $10.62. Quest Diagnostics also guided revenue in the range of $11.78B - $11.90B for the period.
Compared to prior guidance, Quest Diagnostics raised its EPS outlook from a previous range of $10.50 - $10.70. On the revenue side, the company maintained its revenue forecast from a prior range of $11.70B - $11.82B.
Quest Diagnostics has issued 18 guidance updates between July 21, 2022 and April 21, 2026. During this period, the company raised its outlook 6 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Latest Guidance Date
Apr 21, 2026
Guidance Period
Full Year 2026
EPS Guidance Range
$10.63 - $10.83
Revenue Guidance Range
$11.78B - $11.90B
Quest Diagnostics Guidance History
Review all historical guidance issued by Quest Diagnostics, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Quest Diagnostics (DGX)?
The most recent guidance for Quest Diagnostics (DGX) was reported on April 21, 2026 for the fiscal year 2026. The company provided earnings per share guidance in the range of $10.63 to $10.83, compared to the estimated EPS of $10.62. Additionally, Quest Diagnostics forecasted revenue between $11.78B and $11.90B for the period.
What EPS range did Quest Diagnostics (DGX) guide for?
Quest Diagnostics (DGX) guided EPS in the range of $10.63 to $10.83 for the fiscal year 2026. The consensus analyst EPS estimate is $10.62.
What revenue range did Quest Diagnostics (DGX) guide for?
Quest Diagnostics (DGX) guided revenue in the range of $11.78B to $11.90B for the fiscal year 2026.
Did Quest Diagnostics (DGX) raise or lower guidance?
Quest Diagnostics (DGX) raised its EPS guidance from a prior range of $10.50 - $10.70 to $10.63 - $10.83 for the fiscal year 2026.
When did Quest Diagnostics (DGX) last issue guidance?
Quest Diagnostics (DGX) last issued guidance on April 21, 2026 for the fiscal year 2026.
